Biolargo Inc (BLGO) Financial Statements (2026 and earlier)

Company Profile

Business Address 14921 CHESTNUT ST.
WESTMINSTER, CA 92683
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 28 - Chemicals And Allied Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,8833,5483,5391,851962716
Cash and cash equivalent3,8833,5483,5391,851962716
Receivables6153,1682,6121,064513484
Inventory, net of allowances, customer advances and progress billings310330153120241277
Inventory310330153120241277
Other undisclosed current assets30691581188528
Total current assets:5,1147,1376,3623,1531,8011,505
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization338451    
Operating lease, right-of-use asset1,0289921,092867453341
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization1,6431,7426622876160
Long-term investments and receivables  9619334863
Long-term investments  1419334863
Accounts and financing receivable, after allowance for credit loss  82    
Intangible asset, including goodwill, after accumulated amortization      2,150
Intangible asset, excluding goodwill, after accumulated amortization      2,150
Prepaid expense    394591788
Other noncurrent assets10695701246935
Other undisclosed noncurrent assets82     
Total noncurrent assets:3,1973,3761,8431,7051,2223,437
TOTAL ASSETS:8,31110,5138,2054,8583,0234,942
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,2119461,488940559513
Interest and dividends payable✕✕✕✕✕2542
Employee-related liabilities✕✕✕✕✕184156
Accounts payable1,0128261,212717350315
Accrued liabilities199120276223  
Deferred revenue280 303178948
Debt103640661003141,206
Other undisclosed current liabilities3,4691,0628535194121,777
Total current liabilities:5,0632,6482,7101,5761,3743,544
Noncurrent Liabilities
Long-term debt and lease obligation257360289237529733
Long-term debt, excluding current maturities   289237180507
Finance lease, liability257360    
Liabilities, other than long-term debt8649221,004773 900
Financial instruments subject to mandatory redemption, settlement terms, share value, amount      900
Operating lease, liability8649221,004773349226
Other undisclosed noncurrent liabilities601527 261(162) 
Total noncurrent liabilities:1,7221,8091,2931,2717161,633
Total liabilities:6,7854,4574,0032,8472,0905,177
Equity
Equity, attributable to parent4,0428,8516,8444,8784,6533,858
Common stock213202196186171151
Additional paid in capital165,316158,332154,023148,435143,718135,849
Accumulated other comprehensive loss(207)(183)(277)(149)(115)(101)
Accumulated deficit(161,280)(149,500)(147,098)(143,594)(139,121)(132,041)
Equity, attributable to noncontrolling interest(2,516)(2,795)(2,642)(2,867)(3,720)(4,093)
Total equity:1,5266,0564,2022,011933(235)
TOTAL LIABILITIES AND EQUITY:8,31110,5138,2054,8583,0234,942

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues7,76517,77912,2305,8842,5312,432
Cost of revenue
(Cost of Product and Service Sold)		(4,359)(9,926)(6,076)(3,027)(1,428)(1,204)
Gross profit:3,4067,8536,1542,8571,1031,228
Operating expenses(18,261)(12,184)(10,734)(8,247)(7,539)(8,811)
Operating loss:(14,855)(4,331)(4,580)(5,390)(6,436)(7,583)
Nonoperating income (expense)(334)(16)(68)258(458)(2,117)
Investment income, nonoperating200     
Government assistance, nonoperating income, increase (decrease)  26✕✕✕✕
Other nonoperating income (expense)   (68)258(458)(2,117)
Interest and debt expense(540)(66)(91)(53)(234)(2,365)
Other undisclosed income from continuing operations before equity method investments, income taxes540     
Loss from continuing operations before equity method investments, income taxes:(15,189)(4,413)(4,739)(5,185)(7,128)(12,065)
Loss from equity method investments(14)   (15)(37)
Loss from continuing operations:(15,203)(4,413)(4,739)(5,185)(7,143)(12,102)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(7,143)(12,102)
Other undisclosed net income146691532492,402
Net loss:(15,189)(4,347)(4,648)(5,132)(6,894)(9,700)
Net income attributable to noncontrolling interest3,4091,9451,144659  
Net loss attributable to parent:(11,780)(2,402)(3,504)(4,473)(6,894)(9,700)
Other undisclosed net income (loss) available to common stockholders, basic     (186)1,268
Net loss available to common stockholders, diluted:(11,780)(2,402)(3,504)(4,473)(7,080)(8,432)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(15,189)(4,347)(4,648)(5,132)(6,894)(9,700)
Other undisclosed comprehensive income (loss)(24)94(128)(34)(14)(2)
Comprehensive loss:(15,213)(4,253)(4,776)(5,166)(6,908)(9,702)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest3,4091,9451,144659(186)1,268
Comprehensive loss, net of tax, attributable to parent:(11,804)(2,308)(3,632)(4,507)(7,094)(8,434)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: